NCT05667324View on ClinicalTrials.gov

Septorhinoplasty Post-operative Pain Control With SPG Nerve Block

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 12, 2023

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
Deviated Nasal Septum
Interventions
DRUG

Ropivacaine

A single injection into the pterygopalatine fossa bilaterally of 0.5% ropivacaine at a dose of 20 mg (each side)

DRUG

Dexamethasone

Plus 4 mg dexamethasone

DRUG

Placebo

A single injection into the pterygopalatine fossa bilaterally of a balanced crystalloid intravenous solution (4 ml of normal saline)

Trial Locations (1)

32610

UF Health of University of Florida, Gainesville

All Listed Sponsors
lead

University of Florida

OTHER